Do analysts recommend ATNM or BFRG?

Actinium Pharmaceuticals presently has a consensus price target of $4.50, suggesting a potential upside of 316.67%. Given Actinium Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Actinium Pharmaceuticals is more favorable than Bullfrog AI. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Actinium Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Bullfrog AI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ATNM or BFRG more profitable?

Actinium Pharmaceuticals' return on equity of -100.85% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets Actinium Pharmaceuticals N/A -100.85% -47.89% Bullfrog AI N/A -217.80% -174.57%

Does the media favor ATNM or BFRG?

In the previous week, Actinium Pharmaceuticals had 6 more articles in the media than Bullfrog AI. MarketBeat recorded 7 mentions for Actinium Pharmaceuticals and 1 mentions for Bullfrog AI. Actinium Pharmaceuticals' average media sentiment score of 0.24 beat Bullfrog AI's score of 0.00 indicating that Actinium Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Actinium Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bullfrog AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer BFRG or PYRGF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Does the media prefer BFRG or PYRGF?

In the previous week, PyroGenesis Canada had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 2 mentions for PyroGenesis Canada and 1 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 0.00 equaled PyroGenesis Canada'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bullfrog AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PyroGenesis Canada 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate BFRG or ATHE?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bullfrog AI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Alterity Therapeutics 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation and earnings, BFRG or ATHE?

Bullfrog AI has higher revenue and earnings than Alterity Therapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bullfrog AI $116.67K 72.83 -$6.50M -$0.54 N/A Alterity Therapeutics N/A N/A -$7.87M N/A N/A

Is BFRG or ATHE more profitable?

Alterity Therapeutics' return on equity of 0.00% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets Bullfrog AI N/A -217.80% -174.57% Alterity Therapeutics N/A N/A N/A

Do analysts prefer IXHL or BFRG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Incannex Healthcare 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Bullfrog AI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is IXHL or BFRG more profitable?

Incannex Healthcare's return on equity of -81.01% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets Incannex Healthcare N/A -81.01% -76.11% Bullfrog AI N/A -217.80% -174.57%

Do analysts recommend INMB or BFRG?

INmune Bio currently has a consensus target price of $8.00, indicating a potential upside of 534.92%. Given INmune Bio's stronger consensus rating and higher probable upside, equities research analysts plainly believe INmune Bio is more favorable than Bullfrog AI. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score INmune Bio 2 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.17 Bullfrog AI 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is INMB or BFRG more profitable?

INmune Bio's return on equity of -103.03% beat Bullfrog AI's return on equity. Company Net Margins Return on Equity Return on Assets INmune Bio N/A -103.03% -77.66% Bullfrog AI N/A -217.80% -174.57%

Does the media favor INMB or BFRG?

In the previous week, INmune Bio and INmune Bio both had 1 articles in the media. INmune Bio's average media sentiment score of 0.00 equaled Bullfrog AI'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment INmune Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bullfrog AI 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Bullfrog AI (BFRG) Competitors

$0.67 -0.10 (-12.82%)

Closing price 04:00 PM Eastern

Extended Trading

$0.68 +0.01 (+2.09%)

As of 07:54 PM Eastern

Compare

BFRG vs. ATNM, PYRGF, ATHE, IXHL, and INMB

Should you buy Bullfrog AI stock or one of its competitors? MarketBeat compares Bullfrog AI with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Bullfrog AI include Actinium Pharmaceuticals (ATNM), PyroGenesis Canada (PYRGF), Alterity Therapeutics (ATHE), Incannex Healthcare (IXHL), and INmune Bio (INMB). These companies are all part of the "pharmaceutical products" industry.

How does Bullfrog AI compare to Actinium Pharmaceuticals?

Actinium Pharmaceuticals (NYSE:ATNM) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations.

In the previous week, Actinium Pharmaceuticals had 6 more articles in the media than Bullfrog AI. MarketBeat recorded 7 mentions for Actinium Pharmaceuticals and 1 mentions for Bullfrog AI. Actinium Pharmaceuticals' average media sentiment score of 0.24 beat Bullfrog AI's score of 0.00 indicating that Actinium Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Actinium Pharmaceuticals	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bullfrog AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Actinium Pharmaceuticals presently has a consensus price target of $4.50, suggesting a potential upside of 316.67%. Given Actinium Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Actinium Pharmaceuticals is more favorable than Bullfrog AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Actinium Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Bullfrog AI	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

27.5% of Actinium Pharmaceuticals shares are owned by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are owned by institutional investors. 0.6% of Actinium Pharmaceuticals shares are owned by company insiders. Comparatively, 25.2% of Bullfrog AI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Bullfrog AI has higher revenue and earnings than Actinium Pharmaceuticals. Actinium Pharmaceuticals is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Actinium Pharmaceuticals	$90K	376.50	-$48.82M	-$0.75	N/A
Bullfrog AI	$116.67K	72.83	-$6.50M	-$0.54	N/A

Actinium Pharmaceuticals has a beta of -0.06, meaning that its stock price is 106% less volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.89, meaning that its stock price is 389% less volatile than the broader market.

Actinium Pharmaceuticals' return on equity of -100.85% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Actinium Pharmaceuticals	N/A	-100.85%	-47.89%
Bullfrog AI	N/A	-217.80%	-174.57%

Summary

Actinium Pharmaceuticals beats Bullfrog AI on 11 of the 15 factors compared between the two stocks.

How does Bullfrog AI compare to PyroGenesis Canada?

Bullfrog AI (NASDAQ:BFRG) and PyroGenesis Canada (NASDAQ:PYRGF) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
PyroGenesis Canada	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, PyroGenesis Canada had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 2 mentions for PyroGenesis Canada and 1 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 0.00 equaled PyroGenesis Canada'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bullfrog AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PyroGenesis Canada	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Bullfrog AI has a beta of -2.89, suggesting that its stock price is 389% less volatile than the broader market. Comparatively, PyroGenesis Canada has a beta of 0.19, suggesting that its stock price is 81% less volatile than the broader market.

Bullfrog AI has higher earnings, but lower revenue than PyroGenesis Canada. PyroGenesis Canada is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$116.67K	72.83	-$6.50M	-$0.54	N/A
PyroGenesis Canada	$9.14M	3.99	-$21.12M	-$0.04	N/A

Bullfrog AI has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-217.80%	-174.57%
PyroGenesis Canada	-115.14%	N/A	-60.81%

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 0.0% of PyroGenesis Canada shares are owned by institutional investors. 25.2% of Bullfrog AI shares are owned by insiders. Comparatively, 47.7% of PyroGenesis Canada shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

PyroGenesis Canada beats Bullfrog AI on 7 of the 13 factors compared between the two stocks.

How does Bullfrog AI compare to Alterity Therapeutics?

Bullfrog AI (NASDAQ:BFRG) and Alterity Therapeutics (NASDAQ:ATHE) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends.

Alterity Therapeutics' return on equity of 0.00% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bullfrog AI	N/A	-217.80%	-174.57%
Alterity Therapeutics	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bullfrog AI	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Alterity Therapeutics	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

1.0% of Bullfrog AI shares are owned by institutional investors. Comparatively, 2.1% of Alterity Therapeutics shares are owned by institutional investors. 25.2% of Bullfrog AI shares are owned by insiders. Comparatively, 38.8% of Alterity Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Bullfrog AI had 1 more articles in the media than Alterity Therapeutics. MarketBeat recorded 1 mentions for Bullfrog AI and 0 mentions for Alterity Therapeutics. Bullfrog AI's average media sentiment score of 0.00 equaled Alterity Therapeutics'average media sentiment score.

Company	Overall Sentiment
Bullfrog AI	Neutral
Alterity Therapeutics	Neutral

Bullfrog AI has higher revenue and earnings than Alterity Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bullfrog AI	$116.67K	72.83	-$6.50M	-$0.54	N/A
Alterity Therapeutics	N/A	N/A	-$7.87M	N/A	N/A

Bullfrog AI has a beta of -2.89, meaning that its share price is 389% less volatile than the broader market. Comparatively, Alterity Therapeutics has a beta of 0.3, meaning that its share price is 70% less volatile than the broader market.

Summary

Alterity Therapeutics beats Bullfrog AI on 7 of the 10 factors compared between the two stocks.

How does Bullfrog AI compare to Incannex Healthcare?

Incannex Healthcare (NASDAQ:IXHL) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.

0.4% of Incannex Healthcare shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 1.3% of Incannex Healthcare shares are held by company insiders. Comparatively, 25.2% of Bullfrog AI shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Bullfrog AI had 1 more articles in the media than Incannex Healthcare. MarketBeat recorded 1 mentions for Bullfrog AI and 0 mentions for Incannex Healthcare. Incannex Healthcare's average media sentiment score of 0.00 equaled Bullfrog AI'saverage media sentiment score.

Company	Overall Sentiment
Incannex Healthcare	Neutral
Bullfrog AI	Neutral

Bullfrog AI has higher revenue and earnings than Incannex Healthcare. Incannex Healthcare is trading at a lower price-to-earnings ratio than Bullfrog AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Incannex Healthcare	$90K	388.36	-$46.88M	-$1.55	N/A
Bullfrog AI	$116.67K	72.83	-$6.50M	-$0.54	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Incannex Healthcare	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Bullfrog AI	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Incannex Healthcare's return on equity of -81.01% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Incannex Healthcare	N/A	-81.01%	-76.11%
Bullfrog AI	N/A	-217.80%	-174.57%

Incannex Healthcare has a beta of 7, indicating that its stock price is 600% more volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.89, indicating that its stock price is 389% less volatile than the broader market.

Summary

Bullfrog AI beats Incannex Healthcare on 7 of the 11 factors compared between the two stocks.

How does Bullfrog AI compare to INmune Bio?

INmune Bio (NASDAQ:INMB) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, media sentiment, dividends, institutional ownership and profitability.

INmune Bio's return on equity of -103.03% beat Bullfrog AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INmune Bio	N/A	-103.03%	-77.66%
Bullfrog AI	N/A	-217.80%	-174.57%

INmune Bio currently has a consensus target price of $8.00, indicating a potential upside of 534.92%. Given INmune Bio's stronger consensus rating and higher probable upside, equities research analysts plainly believe INmune Bio is more favorable than Bullfrog AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INmune Bio	2 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.17
Bullfrog AI	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, INmune Bio and INmune Bio both had 1 articles in the media. INmune Bio's average media sentiment score of 0.00 equaled Bullfrog AI'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
INmune Bio	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bullfrog AI	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

INmune Bio has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market. Comparatively, Bullfrog AI has a beta of -2.89, suggesting that its share price is 389% less volatile than the broader market.

12.7% of INmune Bio shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 21.4% of INmune Bio shares are held by insiders. Comparatively, 25.2% of Bullfrog AI shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Bullfrog AI has higher revenue and earnings than INmune Bio. Bullfrog AI is trading at a lower price-to-earnings ratio than INmune Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INmune Bio	N/A	N/A	-$45.93M	-$1.67	N/A
Bullfrog AI	$116.67K	72.83	-$6.50M	-$0.54	N/A

Summary

INmune Bio beats Bullfrog AI on 9 of the 13 factors compared between the two stocks.

Get Bullfrog AI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BFRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BFRG vs. The Competition

Export

Metric	Bullfrog AI	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$8.50M	$1.53B	$6.44B	$11.97B
Dividend Yield	N/A	N/A	2.69%	5.32%
P/E Ratio	-1.24	78.19	23.77	23.66
Price / Sales	72.83	6.02	488.50	86.29
Price / Cash	N/A	22.84	41.39	55.53
Price / Book	3.53	4.77	9.76	6.39
Net Income	-$6.50M	-$54.76M	$3.56B	$337.36M
7 Day Performance	-11.43%	-2.41%	-3.19%	-3.07%
1 Month Performance	-7.06%	5.27%	-0.11%	0.37%
1 Year Performance	-59.21%	-2.71%	25.29%	27.87%

Bullfrog AI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BFRG Bullfrog AI	0.3731 of 5 stars	$0.67 -12.8%	N/A	-55.3%	$8.50M	$116.67K	N/A	4	Gap Down
ATNM Actinium Pharmaceuticals	2.949 of 5 stars	$1.22 flat	$4.50 +268.9%	-35.1%	$38.28M	$90K	N/A	30	News Coverage Analyst Revision Gap Up
PYRGF PyroGenesis Canada	N/A	$0.18 -10.1%	N/A	-52.9%	$38.12M	$9.14M	N/A	90	News Coverage Gap Down
ATHE Alterity Therapeutics	0.7814 of 5 stars	$4.09 +1.7%	N/A	-17.3%	$36.28M	N/A	N/A	10	Positive News Short Interest Decrease
IXHL Incannex Healthcare	0.4652 of 5 stars	$3.03 -0.7%	N/A	-44.1%	$36.25M	N/A	N/A	3	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BFRG) was last updated on 6/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bullfrog AI (BFRG) Competitors

BFRG vs. ATNM, PYRGF, ATHE, IXHL, and INMB

How does Bullfrog AI compare to Actinium Pharmaceuticals?

Summary

How does Bullfrog AI compare to PyroGenesis Canada?

Summary

How does Bullfrog AI compare to Alterity Therapeutics?

Summary

How does Bullfrog AI compare to Incannex Healthcare?

Summary

How does Bullfrog AI compare to INmune Bio?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BFRG vs. The Competition

Bullfrog AI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bullfrog AI (BFRG) Competitors

BFRG vs. ATNM, PYRGF, ATHE, IXHL, and INMB

How does Bullfrog AI compare to Actinium Pharmaceuticals?

Does the media favor ATNM or BFRG?

Do analysts recommend ATNM or BFRG?

Do institutionals and insiders hold more shares of ATNM or BFRG?

Which has preferable earnings & valuation, ATNM or BFRG?

Which has more volatility & risk, ATNM or BFRG?

Is ATNM or BFRG more profitable?

Summary

How does Bullfrog AI compare to PyroGenesis Canada?

Do analysts prefer BFRG or PYRGF?

Does the media prefer BFRG or PYRGF?

Which has more volatility and risk, BFRG or PYRGF?

Which has preferable earnings & valuation, BFRG or PYRGF?

Is BFRG or PYRGF more profitable?

Do institutionals & insiders hold more shares of BFRG or PYRGF?

Summary

How does Bullfrog AI compare to Alterity Therapeutics?

Is BFRG or ATHE more profitable?

Do analysts rate BFRG or ATHE?

Do insiders & institutionals have more ownership in BFRG or ATHE?

Does the media refer more to BFRG or ATHE?

Which has preferable valuation and earnings, BFRG or ATHE?

Which has more volatility and risk, BFRG or ATHE?

Summary

How does Bullfrog AI compare to Incannex Healthcare?

Do insiders and institutionals have more ownership in IXHL or BFRG?

Does the media refer more to IXHL or BFRG?

Which has preferable earnings and valuation, IXHL or BFRG?

Do analysts prefer IXHL or BFRG?

Is IXHL or BFRG more profitable?

Which has more risk and volatility, IXHL or BFRG?

Summary

How does Bullfrog AI compare to INmune Bio?

Is INMB or BFRG more profitable?

Do analysts recommend INMB or BFRG?

Does the media favor INMB or BFRG?

Which has more risk and volatility, INMB or BFRG?

Do insiders & institutionals have more ownership in INMB or BFRG?

Which has preferable valuation & earnings, INMB or BFRG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BFRG vs. The Competition

Bullfrog AI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools